Publicité
Vivalytic SARS-CoV-2 DT, Flu A/B, RSV
SARS-CoV-2 P.3**
Influenza A/Texas/50/2012 (H3N2)
(500 TCID
/ml, Zeptometrix***)
50
Influenza A/Perth/16/2009
(100 TCID
/ml, Zeptometrix***)
50
Influenza A/Brisbane/10/2007 H3
Culture fluid
(5 TCID
/ml, Zeptometrix***)
50
Influenza A/Hong Kong/4801/2014
(H3N2)
(0,5 TCID
/ml, Zeptometrix***)
50
Influenza A/California/07/09
(50 TCID
/ml, Zeptometrix***)
50
*
Experimentally verified, tested at 492 viral copies.
** Strains validated for inclusivity via BLAST alignment.
*** Experimentally verified using a spiking approach in eNAT® (COPAN) plus 1000
hPBTEC (human primary bronchial/tracheal epithelial cells).
– Annex
Influenza B B/Phuket/3073/2013
(Yamagata-Line)**
Influenza B B/Washington/02/2019
(Victoria-Line)**
B/Colorado/06/2017
(Victoria-Line)**
Influenza B B/Brisbane/60/2008
(Victoria-Line)**
RSV A**
RSV B**
145
Publicité
